[ad_1]
Sai Life Sciences has established a specialized Peptide Research Center at its Hyderabad campus. The facility is equipped with automated synthesis platforms, robotics, and high-throughput systems to support pharmaceutical innovators in developing complex peptide molecules and conjugates. The automation and robotics implemented at the facility could reduce development timelines while improving reproducibility. This investment addresses the increasing industry demand for peptide drugs, which offer advantages like targeted therapeutic effects and reduced side effects compared to traditional small-molecule medicines.
The Peptide Research Center integrates with Sai Life Sciences’ existing drug discovery services, which include medicinal chemistry, biology, and toxicology, to create an end-to-end solution for clients advancing peptide therapies. Drug developers working on metabolic disorders, oncology, or immunotherapies — where peptides show particular promise — may benefit from Sai’s ability to streamline early-stage research through clinical-scale production.
Image Credit: Sai Life Sciences
[ad_2]
Source link
